Brief: Rubius Therapeutics Reports Q4 Loss Per Share Of $0.35

Rubius Therapeutics

28/03/2019 12:10

March 28 (Reuters) - Rubius Therapeutics Inc  RUBY.O :
    * RUBIUS THERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR
2018
FINANCIAL RESULTS WITH BUSINESS UPDATES
    * Q4 LOSS PER SHARE $0.35
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.42 -- REFINITIV IBES
DATA
    * AS OF DECEMBER 31, 2018, CASH, CASH EQUIVALENTS AND
INVESTMENTS
WERE $404.1 MILLION
    * CASH, CASH EQUIVALENTS AND INVESTMENTS AS OF DECEMBER 31
PROVIDING RUBIUS WITH A CASH RUNWAY INTO 2021

Source text for Eikon:  ID:nGNX7hDY7y 
Further company coverage:  RUBY.O 

 (Reuters.Briefs@thomsonreuters.com)